Boundless Bio, Inc.
BOLD
$1.06
-$0.02-1.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.49M | 19.64M | 19.45M | 18.00M | 16.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.83M | 71.40M | 73.73M | 73.27M | 68.79M |
| Operating Income | -67.83M | -71.40M | -73.73M | -73.27M | -68.79M |
| Income Before Tax | -61.76M | -64.39M | -65.69M | -65.36M | -61.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.76 | -64.39 | -65.69 | -65.36 | -61.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.76M | -64.39M | -65.69M | -65.36M | -61.06M |
| EBIT | -67.83M | -71.40M | -73.73M | -73.27M | -68.79M |
| EBITDA | -66.59M | -70.20M | -72.59M | -72.18M | -67.75M |
| EPS Basic | -2.77 | -2.89 | -2.96 | -14.52 | -23.55 |
| Normalized Basic EPS | -1.73 | -1.80 | -1.85 | -9.07 | -14.72 |
| EPS Diluted | -2.77 | -2.89 | -2.96 | -14.52 | -23.55 |
| Normalized Diluted EPS | -1.73 | -1.80 | -1.85 | -9.07 | -14.72 |
| Average Basic Shares Outstanding | 89.33M | 89.19M | 88.86M | 67.82M | 46.78M |
| Average Diluted Shares Outstanding | 89.33M | 89.19M | 88.86M | 67.82M | 46.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |